Merino, Jose G. MD, MPhil; Editor-in-Chief, Neurology®
doi : 10.1212/WNL.0000000000201406
Volume 99(22) pgs. 971-1014,e2428-e2534 November 29, 2022
Barber, Daniel J. MBBS; Masters, Colin L. MD
O'Carroll, Cumara B. MD, MPH; Dumitrascu, Oana MD, MSc
Quispialaya, Kely Monica MD *; Therriault, Joseph BSc *; Aliaga, Antonio MSc; Zimmermann, Maria BSc; Fernandez-Arias, Jaime MSc; Lussier, Firoza MSc; Massarweh, Gassan PhD; Pascoal, Tharick MD, PhD; Soucy, Jean-Paul MD, MSc; Gauthier, Serge MD; Jean-Claude, Bertrand PhD; Gilfix, Brian MD, PhD; Vitali, Paolo MD, PhD; Rosa-Neto, Pedro MD, PhD
doi : 10.1212/WNL.0000000000201198
To assess the concordance and discordance between the core Alzheimer disease (AD) CSF biomarkers and [18F]fluorodeoxyglucose (FDG)-PET patterns evaluated clinically in memory clinic patients who meet appropriate use criteria for AD biomarker investigations. Methods: We retrospectively assessed participants with atypical and/or early-onset dementia evaluated at a tertiary care memory clinic.
Sasaki, Ryogen MD, PhD; Morimoto, Satoru MD, PhD; Ozawa, Fumiko; Okano, Hideyuki MD, PhD; Yoshida, Mari MD, PhD; Ishiura, Hiroyuki MD, PhD; Tsuji, Shoji MD; Kuzuhara, Shigeki MD, PhD; Kokubo, Yasumasa MD, PhD
doi : 10.1212/WNL.0000000000201156
To examine the association of the APOE [epsilon]4 and [epsilon]2 alleles with the pathologic features of patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex cases in the Kii peninsula of Japan (Kii ALS/PDC).
Zhang, Yi MA *; He, Xiaoqin BA *; Mo, Chengjun BA *; Liu, Xiaoqian BA; Li, Jian PhD; Yan, Zheng MA; Qian, Yiwei MD, PhD; Lai, Yiqiu BA; Xu, Shaoqing MD, PhD; Yang, Xiaodong MD, PhD +; Xiao, Qin MD, PhD +
doi : 10.1212/WNL.0000000000201204
Interindividual variability in levodopa efficacy is a challenge for the personalized treatment of Parkinson disease (PD). Gut microbiota might represent a new approach for personalized medicine.
Jochems, Angela C.C. MSc *; Arteaga, Carmen MD *; Chappell, Francesca PhD; Ritakari, Tuula PhD; Hooley, Monique PhD; Doubal, Fergus MBChB, PhD; Munoz Maniega, Susana PhD; Wardlaw, Joanna M. MD
doi : 10.1212/WNL.0000000000201205
White matter hyperintensities (WMHs) are frequent imaging features of small vessel disease (SVD) and related to poor clinical outcomes. WMH progression over time is well described, but regression was also noted recently, although the frequency and associated factors are unknown. This systematic review and meta-analysis aims to assess longitudinal intraindividual WMH volume changes in sporadic SVD.
Robinson, David Joseph MD, MS *; Stanton, Robert MD *; Sucharew, Heidi PhD; Alwell, Kathleen BSN; Haverbusch, Mary BSN; De Los Rios La Rosa, Felipe MD, FAHA; Ferioli, Simona MD; Coleman, Elisheva MD; Jasne, Adam MD; Mackey, Jason MD; Star, Michael MD; Mistry, Eva A. MD; Demel, Stacie DO, PhD; Slavin, Sabreena MD; Walsh, Kyle MD; Woo, Daniel MD; Kissela, Brett MD, MS; Kleindorfer, Dawn O. MD
doi : 10.1212/WNL.0000000000201225
There are significant racial disparities in stroke in the United States, with Black individuals having a higher risk of incident stroke even when adjusted for traditional stroke risk factors. It is unknown whether Black individuals are also at a higher risk of recurrent stroke.
Tian, Fei MD; Cai, Miao PhD; Li, Haitao PhD; Qian, Zhengmin (Min) PhD; Chen, Lan MD; Zou, Hongtao MD; Zhang, Zilong PhD; Wang, Chongjian PhD; Xian, Hong PhD; McMillin, Stephen Edward PhD; Lin, Hualiang PhD
doi : 10.1212/WNL.0000000000201316
Ambient air pollution has been widely linked with morbidity and mortality of stroke. However, its effects on dynamic progression trajectory of stroke remain unknown.We investigated the effects of ambient air pollution on progression trajectory from healthy status to incident stroke, poststroke cardiovascular diseases, and subsequent death. Methods: We retrieved 318,752 participants from the UK Biobank.
Marefi, Amaar MD; Husein, Nafisa MSc; Dunbar, Mary MD; Dewey, Deborah MD; Letourneau, Nicole PhD, RN, FAAN, FCAHS; Oskoui, Maryam MDCM; Kirton, Adam MD, MSc; Shevell, Michael I. MDCM; on behalf of the Canadian Cerebral Palsy Registry (CCPR)
doi : 10.1212/WNL.0000000000201274
The aim of this study was to identify possible risk factors associated with term-born children with cerebral palsy (CP) and periventricular white matter injury (PVWMI) on imaging.
Yuskaitis, Christopher J. MD, PhD; Mytinger, John R. MD; Baumer, Fiona M. MD; Zhang, Bo PhD; Liu, Shanshan MS, MPH; Samanta, Debopam MD; Hussain, Shaun A. MD; Yozawitz, Elissa G. MD; Keator, Cynthia G. MD; Joshi, Charuta MD; Singh, Rani K. MD; Bhatia, Sonal MD; Bhalla, Sonam MD; Shellhaas, Renee *; Harini, Chellamani MD *; on behalf of the Pediatric Epilepsy Research Consortium
doi : 10.1212/WNL.0000000000201232
Standard therapies (adrenocorticotropic hormone [ACTH], oral steroids, or vigabatrin) fail to control infantile spasms in almost half of children. Early identification of nonresponders could enable rapid initiation of sequential therapy.
Barreras, Paula MD *; Vasileiou, Eleni S. MD *; Filippatou, Angeliki G. MD; Fitzgerald, Kathryn C. ScD; Levy, Michael MD, PhD; Pardo, Carlos A. MD; Newsome, Scott D. DO; Mowry, Ellen M. MD, MCR; Calabresi, Peter A. MD; Sotirchos, Elias S. MD
doi : 10.1212/WNL.0000000000201260
Rituximab is used widely for relapse prevention in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated disease (MOGAD); however, data regarding the effectiveness and safety of long-term rituximab use in these conditions are limited. In this study, we sought to evaluate long-term clinical outcomes in patients with aquaporin-4 IgG-seropositive (AQP4-IgG+) NMOSD and MOGAD treated with rituximab.
Carotenuto, Antonio MD; Valsasina, Paola MSc; Schoonheim, Menno M. PhD; Geurts, Jeroen J.G. PhD; Barkhof, Frederik MD, PhD; Gallo, Antonio MD, PhD; Tedeschi, Gioacchino MD; Tommasin, Silvia PhD; Pantano, Patrizia MD; Filippi, Massimo MD; Rocca, Maria A. MD; on behalf of the MAGNIMS Study Group
doi : 10.1212/WNL.0000000000201264
In multiple sclerosis (MS), functional networks undergo continuous reconfiguration and topography changes over the disease course. In this study, we aimed to investigate functional network to pography abnormalities in MS and their association with disease phenotype, clinical and cognitive disability, and structural MRI damage.
Gale, Seth A. MD; Heidebrink, Judith MD; Grill, Joshua PhD; Graff-Radford, Jonathan MD; Jicha, Gregory A. MD, PhD; Menard, William BA; Nowrangi, Milap MD; Sami, Susie MA; Sirivong, Shirley BA; Walter, Sarah MSc; Karlawish, Jason MD
doi : 10.1212/WNL.0000000000201347
AB Because information technologies are increasingly used to improve clinical research and care, personal health information (PHI) has wider dissemination than ever before. The 21st Century Cures Act in the United States now requires patient access to many components of the electronic health record (EHR). Although these changes promise to enhance communication and information sharing, they also bring higher risks of unwanted disclosure, both within and outside of health systems.
Ramos, Gabriel Bortoli MD; Ranzani Martins, Rebecca MD; Carvalhinho Carlos de Souza, Julia MD; Falcao, Fernando Cavalcanti de Sa e Benevides MD; Lopes, Cesar Castello Branco MD; Gargioni de Andrade, Andre Luiz MD; Silva, Guilherme Diogo MD
Chaity, Dimitra Khalil MuDr *; Fearon, Conor MRCPI, PhD *; Alexander, Michael MRCPI; Walsh, John MRCPI; Austin, Neil PhD; O'Byrne, James MRCPI, PhD; Pastores, Gregory MD; Merwick, Aine MRCPI, PhD; Saif, Muhammad MRCP UK; O'Dowd, Sean MRCPI, MD
doi : 10.1212/WNL.0000000000201373
AB Metachromatic leukodystrophy (MLD) is a rare inherited lysosomal disorder. The condition progresses relentlessly, with severe disability typically established within 6-14 years of symptom onset. There is no cure, and limited treatment options are available to slow disease progression.
Shoskes, Aaron DO; Hassett, Catherine DO; Dani, Dhimant MD; Majeed, Aneela MD
doi : 10.1212/WNL.0000000000201334
AB Altered mental status in immunosuppressed patients has a wide differential diagnosis. In this case, a 27-year-old man presented with encephalopathy, nausea, vomiting, and fevers. His medical history was significant for acute myeloid leukemia in remission after allogenic hematopoietic stem cell transplantation 17 months prior complicated by graft vs host disease affecting his skin treated with sirolimus.
McKenna, Mary Clare MRCPI; Redmond, Janice MD; Bradley, David PhD; Bede, Peter MD, PhD
de Gusmao, Claudio M. MD; Garcia, Lucas MD; Inuzuka, Luciana Midori MD; Silveira-Moriyama, Laura MD, PhD
Siegler, James E. MD; Galetta, Steven MD, FAAN
Kawada, Tomoyuki
Shen, Chun; Sahakian, Barbara J.; Feng, Jianfeng
Holwerda, Tjalling J.
Shen, Chun; Feng, Jianfeng
Karceski, Steven MD
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟